CANCER BUZZ PODCAST

With the emergence of oral cancer therapies, it is a very exciting time in cancer care. But these treatments can come with adverse events.

Allowing APPs to sign anti-cancer treatment orders not only improves access to high-quality cancer care, it can also free up physician time to see more new patients and streamline clinic workflow.

Patients with blood cancers require better access to clinical trials. The Leukemia and Lymphoma Society's developed a tool that connects patients with clinical trials that best fit their unique needs.

Hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.

Hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.

Wendi Waugh, Director of Cancer Services, Southern Ohio Medical Center, discusses the implementation of a process improvement plan with a focus on enhancing care for patients with advanced NSCLC.

Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves.

Genetic counselors—as members of the cancer care team—can help patients better understand their cancer diagnosis, make informed treatment decisions, and navigate the financial costs of testing.

In this episode, we'll hear how patients with blood cancer are joining the Leukemia & Lymphoma Society National Patient Registry to increase scientific knowledge about COVID-19 vaccination and booster shot efficacy.

As pandemic restrictions begin to loosen in many communities across the country, patients with CLL face greater uncertainty in this “new normal” at an increased risk for contracting COVID-19 and a response to the vaccine.

As the COVID-19 pandemic recedes and restrictions loosens for most of the U.S., we'll discuss how patient education has become even more critical during this transition.

Three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care.

A physician assistant shares the challenges related to COVID-19, the vaccine, and how his program is adapting to keep diagnosed patients with chronic lymphocytic leukemia (CLL) safe.

Learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.

Learn about the latest promising breakthroughs in immunotherapy, the challenges facing their widespread use, and what your cancer team needs to know about the future of cancer treatment.

We take a look at how the COVID-19 pandemic has impacted lung screenings across the country and how oncology teams are adapting their outreach and education to reach as many people as possible.

We mark the beginning of Lung Cancer Awareness Month by looking at the present landscape for the diagnosis and treatment of one of the most common cancers in the world.